Stay updated with breaking news from Personalized Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Regents Professor Petra Fromme, director of the Biodesign Center for Applied Structural Discovery at Arizona State University, to its College of Fell
The latest research study, titled “Global Personalized Medicine Market: Outlook and Forecast 2023-2030,” has been unveiled by Allied Market Research. This comprehensive analysis delves into the market’s risk assessment, while also illuminating potential opportunities. The study equips stakeholders with invaluable in...
Poster presents findings of a study of ~1000 patient samples demonstrating superior accuracy for HemeScreen™ MPN Assay...
Researchers at Case Western Reserve University and the University of Washington expect to gain valuable new insights into highly aggressive prostate cancer by combining artificial intelligence (AI)-powered diagnostic imaging with three-dimensional (3D) tissue imaging.
According to the latest research, the Center for Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University and pharmaceutical companies have collaborated to create artificial intelligence (AI) tools that will help patients with non-small cell lung cancer (NSCLC) based on an analysis of typical tissue biopsy images.